QuiVad
My list

Home / Funds / GSA Capital Partners L.L.P.

GSA Capital Partners L.L.P.

Every short position this fund has disclosed, market by market.

Follow

This fund discloses no open short position today.

Follow by RSS

Get the moves on GSA Capital Partners L.L.P. by mail.

No account: one address, one link to confirm, one link to stop in every message.

History of disclosures

381 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
March 2, 2016Erytech PharmaFrance1.73%August 8, 2016
March 2, 2016VallourecFrance0.61%March 8, 2016
March 1, 2016AdociaFrance0.96%April 12, 2016
March 1, 2016VallourecFrance0.72%March 8, 2016
February 29, 2016AdociaFrance1.01%April 12, 2016
February 29, 2016GenfitFrance0.67%March 10, 2016
February 26, 2016AdociaFrance0.99%April 12, 2016
February 26, 2016VallourecFrance0.67%March 8, 2016
February 25, 2016AdociaFrance1.00%April 12, 2016
February 25, 2016VallourecFrance0.53%March 8, 2016
February 23, 2016GenfitFrance0.79%March 10, 2016
February 22, 2016AdociaFrance0.98%April 12, 2016
February 19, 2016AdociaFrance1.00%April 12, 2016
February 17, 2016Erytech PharmaFrance1.61%August 8, 2016
February 16, 2016AdociaFrance0.91%April 12, 2016
February 16, 2016GenfitFrance0.87%March 10, 2016
February 15, 2016GenfitFrance0.90%March 10, 2016
February 9, 2016GenfitFrance1.08%March 10, 2016
February 9, 2016AdociaFrance0.80%April 12, 2016
February 8, 2016Erytech PharmaFrance1.50%August 8, 2016
February 3, 2016GenfitFrance1.11%March 10, 2016
February 2, 2016GenfitFrance1.08%March 10, 2016
January 26, 2016AdociaFrance0.71%April 12, 2016
January 20, 2016GenfitFrance1.11%March 10, 2016
January 18, 2016AdociaFrance0.60%April 12, 2016
January 12, 2016GenfitFrance1.00%March 10, 2016
January 7, 2016Erytech PharmaFrance1.49%August 8, 2016
January 7, 2016AdociaFrance0.50%April 12, 2016
January 5, 2016GenfitFrance0.90%March 10, 2016
December 24, 2015GenfitFrance0.81%March 10, 2016
December 24, 2015Neopost S.A.France0.48%December 29, 2015
December 18, 2015Erytech PharmaFrance1.59%August 8, 2016
December 16, 2015Erytech PharmaFrance1.60%August 8, 2016
December 14, 2015Innate PharmaFrance0.49%December 16, 2015
December 11, 2015GenfitFrance0.62%March 10, 2016
December 11, 2015Nicox SAFrance0.48%December 15, 2015
December 8, 2015Erytech PharmaFrance1.51%August 8, 2016
December 8, 2015Innate PharmaFrance0.59%December 16, 2015
December 7, 2015Neopost S.A.France0.53%December 29, 2015
December 4, 2015Innate PharmaFrance0.61%December 16, 2015
December 3, 2015Innate PharmaFrance0.59%December 16, 2015
December 3, 2015GenfitFrance0.54%March 10, 2016
December 1, 2015Innate PharmaFrance0.63%December 16, 2015
November 27, 2015Innate PharmaFrance0.54%December 16, 2015
November 23, 2015Erytech PharmaFrance1.70%August 8, 2016
November 12, 2015Nicox SAFrance0.59%December 15, 2015
November 9, 2015CGGFrance0.48%November 11, 2015
November 6, 2015CGGFrance0.50%November 11, 2015
October 30, 2015Innate PharmaFrance0.48%November 3, 2015
October 28, 2015Nicox SAFrance0.69%December 15, 2015

Download 381 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, GSA Capital Partners L.L.P., data as at October 27, 2021, https://www.quivad.com/detenteur/gsa-capital-partners-l-l-p?page=6